A.p. Pharma, Inc. (APPA) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-125.18M
Loss from discontinued operations
Depreciation and amortization	793K
Amortization of debt discount	510K
Stock-based compensation	18.7M
Accounts receivable
Prepaid expenses and other assets	428K
Accounts payable	2.79M
Accrued expenses
Deferred revenue
Net cash used in continuing operating activities
Net cash provided by discontinued operations
Net cash used in operating activities	-95.58M
Purchases of property and equipment	-2.45M
Net cash used in investing activities	10.07M
Advance proceeds from private placement units
Proceeds from convertible note financing
Proceeds from the exercise of stock options	5.72M
Proceeds from the issuance of shares under the Employee Stock Purchase Plan	251K
Net cash provided by financing activities	55.97M
Net increase (decrease) in cash and cash equivalents	-29.54M
Cash and cash equivalents, beginning of period	75.18M
Cash and cash equivalents, end of period	45.64M

Entities mentioned with APPA

View All Entities